R. B. Jones, Ph.D. - Publications

Affiliations: 
2012 University of Toronto, Toronto, ON, Canada 
Area:
Immunology, Public Health

171 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Ottaway Z, Campbell L, Fox J, Burns F, Hamzah L, Kegg S, Rosenvinge M, Schoeman S, Price D, Jones R, Miller RF, Tariq S, Post FA. HIV outcomes during the COVID-19 pandemic in people of Black ethnicities living with HIV in England. Hiv Medicine. PMID 38529684 DOI: 10.1111/hiv.13640  0.479
2024 Ottaway Z, Campbell L, Cechin LR, Patel N, Fox J, Burns F, Hamzah L, Kegg S, Rosenvinge M, Schoeman S, Price D, Jones R, Clarke A, Mann I, Ustianowski A, et al. Clinical epidemiology of COVID-19 in people of black ethnicity living with HIV in the UK. Hiv Medicine. PMID 38213094 DOI: 10.1111/hiv.13611  0.477
2023 Jones R, Jessee MB, Booker R, Martin SL, Vance DE, Fazeli PL. Associations between Estimates of Arterial Stiffness and Cognitive Functioning in Adults with HIV. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 38133605 DOI: 10.1097/QAI.0000000000003374  0.351
2023 Jost S, Lucar O, Lee E, Yoder T, Kroll K, Sugawara S, Smith S, Jones R, Tweet G, Werner A, Tomezsko PJ, Dugan HL, Ghofrani J, Rascle P, Altfeld M, et al. Antigen-specific memory NK cell responses against HIV and influenza use the NKG2/HLA-E axis. Science Immunology. 8: eadi3974. PMID 38064568 DOI: 10.1126/sciimmunol.adi3974  0.426
2023 Kinloch NN, Shahid A, Dong W, Kirkby D, Jones BR, Beelen CJ, MacMillan D, Lee GQ, Mota TM, Sudderuddin H, Barad E, Harris M, Brumme CJ, Jones RB, Brockman MA, et al. HIV reservoirs are dominated by genetically younger and clonally enriched proviruses. Mbio. e0241723. PMID 37971267 DOI: 10.1128/mbio.02417-23  0.558
2023 Matveev VA, Mihelic EZ, Benko E, Budylowski P, Grocott S, Lee T, Korosec CS, Colwill K, Stephenson H, Law R, Ward LA, Sheikh-Mohamed S, Mailhot G, Delgado-Brand M, Pasculescu A, ... ... Jones RB, et al. Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV. Iscience. 26: 107915. PMID 37790281 DOI: 10.1016/j.isci.2023.107915  0.694
2023 Herrera A, Jones RB. Whack-a-virus: HIV-specific T cells play an exhausting game. Cell Host & Microbe. 31: 1427-1430. PMID 37708850 DOI: 10.1016/j.chom.2023.08.013  0.603
2023 Gunst JD, Højen JF, Pahus MH, Rosás-Umbert M, Stiksrud B, McMahon JH, Denton PW, Nielsen H, Johansen IS, Benfield T, Leth S, Gerstoft J, Østergaard L, Schleimann MH, Olesen R, ... ... Jones RB, et al. Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial. Nature Medicine. PMID 37696935 DOI: 10.1038/s41591-023-02547-6  0.414
2023 Copertino DC, Holmberg CS, Weiler J, Ward AR, Howard JN, Levinger C, Pang AP, Corley MJ, Dündar F, Zumbo P, Betel D, Gandhi RT, McMahon DK, Bosch RJ, Linden N, ... ... Jones RB, et al. The latency reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific CD8+ T-cells. Jci Insight. PMID 37581929 DOI: 10.1172/jci.insight.169028  0.507
2023 Ghofrani J, Bowen A, Chen J, Balakrishnan PB, Powell AB, Cherukula K, Cruz CRY, Jones RB, Lynch RM, Sweeney EE, Fernandes R. Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIV. International Journal of Nanomedicine. 18: 4055-4066. PMID 37520301 DOI: 10.2147/IJN.S401304  0.616
2023 Matveev VA, Mihelic EZ, Benko E, Budylowski P, Grocott S, Lee T, Korosec CS, Colwill K, Stephenson H, Law R, Ward LA, Sheikh-Mohamed S, Mailhot G, Delgado-Brand M, Pasculescu A, ... ... Jones RB, et al. Immunogenicity of COVID-19 vaccines and their effect on the HIV reservoir in older people with HIV. Biorxiv : the Preprint Server For Biology. PMID 37502977 DOI: 10.1101/2023.06.14.544834  0.723
2023 Armstrong I, Lacombe-Duncan A, Shokoohi M, Persad Y, Tseng A, Fung R, Underhill A, Côté P, Machouf N, Saucier A, Varriano B, Brundage M, Jones R, Weisdorf T, Goodhew J, et al. Feminizing hormone therapy in a Canadian cohort of transgender women with and without HIV. Antiviral Therapy. 28: 13596535231182505. PMID 37289725 DOI: 10.1177/13596535231182505  0.427
2023 Sanders-Beer BE, Archin NM, Brumme ZL, Busch M, Deleage C, O'Doherty U, Hughes SH, Jerome K, Jones RB, Karn J, Kearney MF, Keele B, Kulpa D, Laird G, Li JZ, et al. Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop Summary. Aids Research and Human Retroviruses. PMID 37126090 DOI: 10.1089/AID.2022.0188  0.523
2023 Kinloch NN, Shahid A, Dong W, Kirkby D, Jones BR, Beelen CJ, MacMillan D, Lee GQ, Mota TM, Sudderuddin H, Barad E, Harris M, Brumme CJ, Jones RB, Brockman MA, et al. HIV reservoirs are dominated by genetically younger and clonally enriched proviruses. Biorxiv : the Preprint Server For Biology. PMID 37090500 DOI: 10.1101/2023.04.12.536611  0.454
2023 Mutascio S, Mota T, Franchitti L, Sharma AA, Willemse A, Bergstresser SN, Wang H, Statzu M, Tharp GK, Weiler J, Sékaly RP, Bosinger SE, Paiardini M, Silvestri G, Jones RB, et al. CD8 T cells promote HIV latency by remodeling CD4 T cell metabolism to enhance their survival, quiescence, and stemness. Immunity. PMID 37030290 DOI: 10.1016/j.immuni.2023.03.010  0.617
2023 Archin N, Bar KJ, Burdo T, Caskey M, Chahroudi A, Farzan M, Ho YC, Jones RB, Kearney M, Kuritzkes D, Margolis D, Martinez-Picado J, Okoye A, Salgado M, Stevenson M. Highlights from the Tenth International Workshop on HIV Persistence during Therapy, December 13-16, 2022, Miami, Florida-USA. Journal of Virus Eradication. 9: 100315. PMID 36911658 DOI: 10.1016/j.jve.2023.100315  0.456
2023 Bradshaw D, Khawar A, Patel P, Tosswill J, Brown C, Ogaz D, Mason E, Osman R, Mitchell H, Dosekun O, Peris BM, Pickard G, Rayment M, Jones R, Hopkins M, et al. HTLV seroprevalence in people using HIV pre-exposure prophylaxis in England. The Journal of Infection. PMID 36773896 DOI: 10.1016/j.jinf.2023.01.033  0.527
2022 Woolley G, Mosher M, Kroll K, Jones R, Hueber B, Sugawara S, Manickam C, Terry K, Varner V, Lifton M, Ram D, Fennessey CM, Keele BF, Reeves RK. Natural Killer Cells Regulate Acute SIV Replication, Dissemination, and Inflammation, but Do Not Impact Independent Transmission Events. Journal of Virology. e0151922. PMID 36511699 DOI: 10.1128/jvi.01519-22  0.444
2022 Gunst JD, Pahus MH, Rosás-Umbert M, Lu IN, Benfield T, Nielsen H, Johansen IS, Mohey R, Østergaard L, Klastrup V, Khan M, Schleimann MH, Olesen R, Støvring H, Denton PW, ... ... Jones RB, et al. Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial. Nature Medicine. PMID 36253609 DOI: 10.1038/s41591-022-02023-7  0.62
2022 Stevenson EM, Terry S, Copertino D, Leyre L, Danesh A, Weiler J, Ward AR, Khadka P, McNeil E, Bernard K, Miller IG, Ellsworth GB, Johnston CD, Finkelsztein EJ, Zumbo P, ... ... Jones RB, et al. SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8 T-cells. Nature Communications. 13: 4888. PMID 35985993 DOI: 10.1038/s41467-022-32376-z  0.625
2022 Linden N, Jones RB. Potential multi-modal effects of provirus integration on HIV-1 persistence: lessons from other viruses. Trends in Immunology. 43: 617-629. PMID 35817699 DOI: 10.1016/j.it.2022.06.001  0.533
2022 Ward AR, Thomas AS, Stevenson EM, Huang SH, Keating SM, Gandhi RT, McMahon DK, Bosch RJ, Macatangay BJ, Cyktor JC, Eron JJ, Mellors JW, Jones RB. No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ART. Aids (London, England). PMID 35730388 DOI: 10.1097/QAD.0000000000003301  0.809
2022 Gruell H, Gunst JD, Cohen YZ, Pahus MH, Malin JJ, Platten M, Millard KG, Tolstrup M, Jones RB, Conce Alberto WD, Lorenzi JCC, Oliveira TY, Kümmerle T, Suárez I, Unson-O'Brien C, et al. Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial. The Lancet. Microbe. 3: e203-e214. PMID 35544074 DOI: 10.1016/S2666-5247(21)00239-1  0.574
2022 Leyre L, Jones RB. Hide and seek: for HIV-infected CD4+ T cells, playing well comes with maturity. The Journal of Clinical Investigation. 132: 1-4. PMID 35362485 DOI: 10.1172/JCI158872  0.519
2022 Ivison GT, Vendrame E, Martínez-Colón GJ, Ranganath T, Vergara R, Zhao NQ, Martin MP, Bendall SC, Carrington M, Cyktor JC, McMahon DK, Eron J, Jones RB, Mellors JW, Bosch RJ, et al. Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients. Frontiers in Cellular and Infection Microbiology. 12: 757846. PMID 35223535 DOI: 10.3389/fcimb.2022.757846  0.591
2021 Deeks SG, Archin N, Cannon P, Collins S, Jones RB, de Jong MAWP, Lambotte O, Lamplough R, Ndung'u T, Sugarman J, Tiemessen CT, Vandekerckhove L, Lewin SR. Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021. Nature Medicine. PMID 34848888 DOI: 10.1038/s41591-021-01590-5  0.579
2021 Gopalakrishnan RM, Aid M, Mercado NB, Davis C, Malik S, Geiger E, Varner V, Jones R, Bosinger SE, Piedra-Mora C, Martinot AJ, Barouch DH, Reeves RK, Tan CS. Increased IL-6 expression precedes reliable viral detection in the rhesus macaque brain during acute SIV infection. Jci Insight. 6. PMID 34676832 DOI: 10.1172/jci.insight.152013  0.315
2021 Li M, Garforth SJ, O'Connor KE, Su H, Lee DM, Celikgil A, Chaparro RJ, Seidel RD, Jones RB, Arav-Boger R, Almo SC, Goldstein H. T-cell receptor-specific immunotherapeutics drive selective in vivo HIV and CMV-specific T-cell expansion in humanized mice. The Journal of Clinical Investigation. PMID 34673568 DOI: 10.1172/JCI141051  0.648
2021 Wilson A, Shakhtour L, Ward A, Ren Y, Recarey M, Stevenson E, Korom M, Kovacs C, Benko E, Jones RB, Lynch RM. Characterizing the Relationship Between Neutralization Sensitivity and Gene Diversity During ART Suppression. Frontiers in Immunology. 12: 710327. PMID 34603284 DOI: 10.3389/fimmu.2021.710327  0.463
2021 Okhai H, Sabin CA, Haag K, Sherr L, Dhairyawan R, Burns F, Gilson R, Post F, Ross J, Mackie N, Sullivan A, Shepherd J, Tariq A, Jones R, Fox J, et al. Menopausal status, age and management among women living with HIV in the UK. Hiv Medicine. PMID 34309177 DOI: 10.1111/hiv.13138  0.317
2021 Hung RKY, Santana-Suarez B, Binns-Roemer E, Campbell L, Bramham K, Hamzah L, Fox J, Burns JE, Clarke A, Vincent R, Jones R, Price DA, Onyango D, Harber M, Hilton R, et al. The epidemiology of kidney disease in people of African ancestry with HIV in the UK. Eclinicalmedicine. 38: 101006. PMID 34286237 DOI: 10.1016/j.eclinm.2021.101006  0.404
2021 Jones R, Kroll K, Broedlow C, Schifanella L, Smith S, Hueber B, Shah SV, Ram DR, Manickam C, Varner V, Klatt NR, Reeves RK. Probiotic supplementation reduces inflammatory profiles but does not prevent oral immune perturbations during SIV infection. Scientific Reports. 11: 14507. PMID 34267278 DOI: 10.1038/s41598-021-93918-x  0.449
2021 Jones R, Manickam C, Ram DR, Kroll K, Hueber B, Woolley G, Shah SV, Smith S, Varner V, Reeves RK. Systemic and mucosal mobilization of granulocyte subsets during lentivirus infection. Immunology. PMID 34037988 DOI: 10.1111/imm.13376  0.317
2021 McCann CD, van Dorp CH, Danesh A, Ward AR, Dilling TR, Mota TM, Zale E, Stevenson EM, Patel S, Brumme CJ, Dong W, Jones DS, Andresen TL, Walker BD, Brumme ZL, ... ... Jones RB, et al. A participant-derived xenograft model of HIV enables long-term evaluation of autologous immunotherapies. The Journal of Experimental Medicine. 218. PMID 33988715 DOI: 10.1084/jem.20201908  0.868
2021 Kinloch NN, Ren Y, Alberto WDC, Dong W, Khadka P, Huang SH, Mota TM, Wilson A, Shahid A, Kirkby D, Harris M, Kovacs C, Benko E, Ostrowski MA, Del Rio Estrada PM, ... ... Jones RB, et al. Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA). Nature Communications. 12: 2958. PMID 33986282 DOI: 10.1038/s41467-021-23515-z  0.829
2021 Ren Y, Huang SH, Macedo AB, Ward AR, Conce Alberto WD, Klevorn T, Leyre L, Copertino DC, Mota TM, Chan D, Truong R, Rohwetter T, Zumbo P, Dündar F, Betel D, ... ... Jones RB, et al. Selective BCL-X Antagonists Eliminate Infected Cells from a Primary Cell Model of HIV Latency but not from Reservoirs. Journal of Virology. PMID 33980597 DOI: 10.1128/JVI.02425-20  0.829
2021 Sarabia I, Huang SH, Ward AR, Jones RB, Bosque A. The Intact Non-Inducible Latent HIV-1 Reservoir is Established In an Primary T Cell Model of Latency. Journal of Virology. PMID 33441346 DOI: 10.1128/JVI.01297-20  0.847
2021 Kinloch NN, Ren Y, Conce Alberto WD, Dong W, Khadka P, Huang SH, Mota TM, Wilson A, Shahid A, Kirkby D, Harris M, Kovacs C, Benko E, Ostrowski MA, Del Rio Estrada PM, ... ... Jones RB, et al. HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA). Nature Communications. 12: 165. PMID 33420062 DOI: 10.1038/s41467-020-20442-3  0.858
2021 Stevenson EM, Ward AR, Truong R, Thomas AS, Huang SH, Dilling TR, Terry S, Bui JK, Mota TM, Danesh A, Lee GQ, Gramatica A, Khadka P, Conce Alberto WD, Gandhi RT, ... ... Jones RB, et al. HIV-specific T-cell responses reflect substantive in vivo interactions with antigen despite long-term therapy. Jci Insight. PMID 33400687 DOI: 10.1172/jci.insight.142640  0.877
2020 Sweeney EE, Balakrishnan PB, Powell AB, Bowen A, Sarabia I, Burga RA, Jones RB, Bosque A, Cruz CRY, Fernandes R. PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor function. Nano Research. 13: 736-744. PMID 34079616 DOI: 10.1007/s12274-020-2684-1  0.481
2020 Keller MD, Harris KM, Jensen-Wachspress MA, Kankate VV, Lang H, Lazarski CA, Durkee-Shock J, Lee PH, Chaudhry K, Webber K, Datar A, Terpilowski M, Reynolds EK, Stevenson EM, Val S, ... ... Jones RB, et al. SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein. Blood. 136: 2905-2917. PMID 33331927 DOI: 10.1182/blood.2020008488  0.314
2020 Jones SG, Jones R, Fenkl EA, Lacroix-Williams L, Simon S, Chadwell K. Acceptability of the "Love, Sex, & Choices" HIV Prevention Intervention by Hispanic Female College Students. Hispanic Health Care International : the Official Journal of the National Association of Hispanic Nurses. 1540415320976644. PMID 33256476 DOI: 10.1177/1540415320976644  0.357
2020 Moron-Lopez S, Telwatte S, Sarabia I, Battivelli E, Montano M, Macedo AB, Aran D, Butte AJ, Jones RB, Bosque A, Verdin E, Greene WC, Wong JK, Yukl SA. Human splice factors contribute to latent HIV infection in primary cell models and blood CD4+ T cells from ART-treated individuals. Plos Pathogens. 16: e1009060. PMID 33253324 DOI: 10.1371/journal.ppat.1009060  0.634
2020 Ren Y, Korom M, Ward AR, Truong R, Chan D, Huang SH, Kovacs CC, Benko E, Safrit JT, Lee J, Garbán H, Lynch R, Jones RB. Relationships between Neutralization, Binding, and ADCC of Broadly Neutralizing Antibodies against Reservoir HIV. Journal of Virology. PMID 33115874 DOI: 10.1128/JVI.01808-20  0.822
2020 Powell AB, Ren Y, Korom M, Saunders D, Hanley PJ, Goldstein H, Nixon DF, Bollard CM, Lynch RM, Jones RB, Cruz CRY. Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV. Molecular Therapy. Methods & Clinical Development. 19: 78-88. PMID 33005704 DOI: 10.1016/J.Omtm.2020.08.015  0.622
2020 Ward AR, Mota TM, Jones RB. Immunological approaches to HIV cure. Seminars in Immunology. 101412. PMID 32981836 DOI: 10.1016/j.smim.2020.101412  0.566
2020 Lima NS, Takata H, Huang SH, Haregot A, Mitchell J, Blackmore S, Garland A, Sy A, Cartwright P, Routy JP, Michael NL, Appay V, Jones RB, Trautmann L. CTL Clonotypes with Higher TCR Affinity Have Better Ability to Reduce the HIV Latent Reservoir. Journal of Immunology (Baltimore, Md. : 1950). PMID 32591402 DOI: 10.4049/jimmunol.1900811  0.865
2020 Sorensen ES, Macedo AB, Resop RS, Howard JN, Nell R, Sarabia I, Newman D, Ren Y, Jones RB, Planelles V, Spivak AM, Bosque A. Structure activity relationship analysis of benzotriazine analogues as HIV-1 Latency Reversing Agents. Antimicrobial Agents and Chemotherapy. PMID 32482680 DOI: 10.1128/Aac.00888-20  0.497
2020 Jones R, Nelson M, Bracchi M, Asboe D, Boffito M. COVID-19 in patients with HIV. The Lancet. Hiv. PMID 32416771 DOI: 10.1016/S2352-3018(20)30139-9  0.508
2020 Hsiao F, Frouard J, Gramatica A, Xie G, Telwatte S, Lee GQ, Roychoudhury P, Schwarzer R, Luo X, Yukl SA, Lee S, Hoh R, Deeks SG, Jones RB, Cavrois M, et al. Tissue memory CD4+ T cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection. Plos Pathogens. 16: e1008450. PMID 32353080 DOI: 10.1371/Journal.Ppat.1008450  0.565
2020 Solomon D, Sabin CA, Burns F, Gilson R, Allan S, de Ruiter A, Dhairyawan R, Fox J, Gilleece Y, Jones R, Post F, Reeves I, Ross J, Ustianowski A, Shepherd J, et al. The association between severe menopausal symptoms and engagement with HIV care and treatment in women living with HIV. Aids Care. 1-8. PMID 32279528 DOI: 10.1080/09540121.2020.1748559  0.36
2020 Mota TM, McCann CD, Danesh A, Huang SH, Magat DB, Ren Y, Leyre L, Bui TD, Rohwetter TM, Kovacs CM, Benko E, MacLaren L, Wimpelberg A, Cannon CC, Hardy WD, ... ... Jones RB, et al. Integrated assessment of viral transcription, antigen presentation, and CD8+ T cell function reveal multiple limitations of class I selective HDACi during HIV-1 latency reversal. Journal of Virology. PMID 32051267 DOI: 10.1128/JVI.01845-19  0.868
2020 Ren Y, Huang SH, Patel S, Conce Alberto WD, Magat D, Ahimovic DJ, Macedo AB, Durga R, Chan D, Zale E, Mota TM, Truong R, Rohwetter T, McCann CD, Kovacs CM, ... ... Jones RB, et al. BCL-2 antagonism sensitizes cytotoxic t cell-resistant hiv reservoirs to elimination ex vivo. The Journal of Clinical Investigation. PMID 32027622 DOI: 10.1172/JCI132374  0.87
2020 Dhummakupt A, Rubens JH, Anderson T, Powell L, Nonyane BA, Siems LV, Collinson-Streng A, Nilles TL, Jones RB, Tepper V, Agwu A, Persaud D. Differences in the induced latent HIV reservoir in perinatal and adult infection. Jci Insight. PMID 31999647 DOI: 10.1172/jci.insight.134105  0.51
2020 Dubrovsky L, Ward A, Choi SH, Pushkarsky T, Brichacek B, Vanpouille C, Adzhubei AA, Mukhamedova N, Sviridov D, Margolis L, Jones RB, Miller YI, Bukrinsky M. Inhibition of HIV Replication by Apolipoprotein A-I Binding Protein Targeting the Lipid Rafts. Mbio. 11. PMID 31964734 DOI: 10.1128/Mbio.02956-19  0.573
2020 Patel S, Hanajiri R, Grant M, Saunders D, Van Pelt S, Keller M, Hanley PJ, Simon G, Nixon DF, Hardy D, Jones RB, Bollard CM. HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform. Molecular Therapy. Methods & Clinical Development. 16: 11-20. PMID 31720305 DOI: 10.1016/j.omtm.2019.10.001  0.662
2020 Sweeney EE, Balakrishnan PB, Powell AB, Bowen A, Sarabia I, Burga RA, Jones RB, Bosque A, Cruz CRY, Fernandes R. PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor function Nano Research. 13: 736-744. DOI: 10.1007/S12274-020-2684-1  0.484
2019 Jones R, Hoover DR, Lacroix LJ, Garvey CM. Correlates of HIV Transmission Behaviors and HIV Testing in Predominately African American/Black Women with High-Risk Male Sex Partners. Aids and Behavior. PMID 31834541 DOI: 10.1007/s10461-019-02762-8  0.407
2019 Hueber B, Curtis AD, Kroll K, Varner V, Jones R, Pathak S, Lifton M, Van Rompay KKA, De Paris K, Reeves RK. Functional perturbation of mucosal group 3 innate lymphoid and natural killer cells in SHIV/SIV-infected infant rhesus macaques. Journal of Virology. PMID 31801861 DOI: 10.1128/JVI.01644-19  0.424
2019 Mota TM, Jones RB. HTLV-1 as a Model for Virus and Host Coordinated Immunoediting. Frontiers in Immunology. 10: 2259. PMID 31616431 DOI: 10.3389/fimmu.2019.02259  0.447
2019 Bendall ML, de Mulder M, Iñiguez LP, Lecanda-Sánchez A, Pérez-Losada M, Ostrowski MA, Jones RB, Mulder LCF, Reyes-Terán G, Crandall KA, Ormsby CE, Nixon DF. Telescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression. Plos Computational Biology. 15: e1006453. PMID 31568525 DOI: 10.1371/Journal.Pcbi.1006453  0.486
2019 Huang SH, McCann CD, Mota TM, Wang C, Lipkin SM, Jones RB. Have Cells Harboring the HIV Reservoir Been Immunoedited? Frontiers in Immunology. 10: 1842. PMID 31447850 DOI: 10.3389/fimmu.2019.01842  0.857
2019 Toorabally N, Mercer CH, Mitchell KR, Blell M, Burns F, Gilson R, McGregor-Read J, Allan S, De Ruiter A, Dhairyawan R, Fox J, Gilleece Y, Jones R, Mackie N, Obeyesekera S, et al. Association of HIV status with sexual function in women aged 45-60 in England: results from two national surveys. Aids Care. 1-10. PMID 31411046 DOI: 10.1080/09540121.2019.1653436  0.426
2019 Keating SM, Jones RB, Lalama CM, Bosch RJ, McMahon D, Hampton D, Cyktor J, Eron JJ, Mellors JW, Busch MP, Gandhi RT. HIV Antibodies Decline During Antiretroviral Therapy but Remain Correlated with HIV DNA and HIV-specific T Cell Responses. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 31045647 DOI: 10.1097/Qai.0000000000002080  0.585
2019 Monel B, McKeon A, Lamothe-Molina P, Jani P, Boucau J, Pacheco Y, Jones RB, Le Gall S, Walker BD. HIV Controllers Exhibit Effective CD8 T Cell Recognition of HIV-1-Infected Non-activated CD4 T Cells. Cell Reports. 27: 142-153.e4. PMID 30943397 DOI: 10.1016/j.celrep.2019.03.016  0.631
2019 Takata H, Kessing C, Sy A, Lima N, Sciumbata J, Mori L, Jones RB, Chomont N, Michael NL, Valente S, Trautmann L. Modeling HIV-1 latency using primary CD4 T cells from HIV-1 infected ART suppressed individuals. Journal of Virology. PMID 30918072 DOI: 10.1128/JVI.02248-18  0.667
2019 Pinzone MR, VanBelzen DJ, Weissman S, Bertuccio MP, Cannon L, Venanzi-Rullo E, Migueles S, Jones RB, Mota T, Joseph SB, Groen K, Pasternak AO, Hwang WT, Sherman B, Vourekas A, et al. Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion. Nature Communications. 10: 728. PMID 30760706 DOI: 10.1038/S41467-019-08431-7  0.531
2019 Jones RB. Current challenges and recent advances in the search for a cure for HIV. Journal of the International Aids Society. 22: e25248. PMID 30734500 DOI: 10.1002/jia2.25248  0.473
2019 Flerin NC, Bardhi A, Zheng JH, Korom M, Folkvord J, Kovacs C, Benko E, Truong R, Mota T, Connick E, Jones RB, Lynch RM, Goldstein H. Establishment of A Novel Humanized Mouse Model To Investigate Activation and Depletion of Patient-Derived HIV Latent Reservoirs. Journal of Virology. PMID 30626677 DOI: 10.1128/Jvi.02051-18  0.557
2018 Osuna CE, Lim SY, Kublin JL, Apps R, Chen E, Mota TM, Huang SH, Ren Y, Bachtel ND, Tsibris AM, Ackerman ME, Jones RB, Nixon DF, Whitney JB. Publisher Correction: Evidence that CD32a does not mark the HIV-1 latent reservoir. Nature. PMID 30315222 DOI: 10.1038/S41586-018-0611-3  0.787
2018 Macedo AB, Novis CL, De Assis CM, Sorensen ES, Moszczynski P, Huang SH, Ren Y, Spivak AM, Jones RB, Planelles V, Bosque A. Dual TLR2 and TLR7 agonists as HIV latency-reversing agents. Jci Insight. 3. PMID 30282829 DOI: 10.1172/Jci.Insight.122673  0.842
2018 Osuna CE, Lim SY, Kublin JL, Apps R, Chen E, Mota TM, Huang SH, Ren Y, Bachtel ND, Tsibris AM, Ackerman ME, Jones RB, Nixon DF, Whitney JB. Evidence that CD32a does not mark the HIV-1 latent reservoir. Nature. 561: E20-E28. PMID 30232424 DOI: 10.1038/S41586-018-0495-2  0.839
2018 Ren Y, Korom M, Truong R, Chan D, Huang SH, Kovacs CC, Benko E, Safrit JT, Lee J, Garbán H, Apps R, Goldstein H, Lynch RM, Jones RB. Susceptibility to Neutralization by Broadly Neutralizing Antibodies Generally Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs. Journal of Virology. PMID 30209173 DOI: 10.1128/Jvi.00895-18  0.825
2018 Bachtel ND, Beckerle GA, Mota T, Rougvie MM, Raposo RA, Jones RB, Nixon DF, Apps R. Expression of host restriction factors by memory CD4+ T cells differs between healthy donors and HIV-1 infected individuals with effective ART. Aids Research and Human Retroviruses. PMID 30198299 DOI: 10.1089/AID.2018.0162  0.576
2018 Jones BR, Kinloch NN, Horacsek J, Ganase B, Harris M, Harrigan PR, Jones RB, Brockman MA, Joy JB, Poon AFY, Brumme ZL. Phylogenetic approach to recover integration dates of latent HIV sequences within-host. Proceedings of the National Academy of Sciences of the United States of America. PMID 30185556 DOI: 10.1073/Pnas.1802028115  0.532
2018 Bachtel ND, Umviligihozo G, Pickering S, Mota T, Liang H, Del Prete GQ, Chatterjee P, Lee GQ, Thomas R, Brockman MA, Neil S, Carrington M, Bwana B, Bangsberg DR, Martin JN, ... ... Jones RB, et al. HLA-C downregulation by HIV-1 adapts to host HLA genotype. Plos Pathogens. 14: e1007257. PMID 30180214 DOI: 10.1371/Journal.Ppat.1007257  0.336
2018 Clutton GT, Jones RB. Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure. Frontiers in Immunology. 9: 1452. PMID 29988382 DOI: 10.3389/fimmu.2018.01452  0.613
2018 Jose S, Hamzah L, Jones R, Williams D, Winston A, Burns F, Phillips AN, Sabin CA, Post FA. Chronic Kidney Disease Risk in African and Caribbean Populations with HIV. The Journal of Infectious Diseases. PMID 29982487 DOI: 10.1093/infdis/jiy397  0.465
2018 Macedo AB, Resop RS, Martins LJ, Szaniawski MA, Sorensen ES, Spivak AM, Nixon DF, Jones RB, Planelles V, Bosque A. Influence of biological sex, age and HIV status in an in vitro primary cell model of HIV latency using a CXCR4 tropic virus. Aids Research and Human Retroviruses. PMID 29926732 DOI: 10.1089/Aid.2018.0098  0.621
2018 Manickam C, Nwanze C, Ram DR, Shah SV, Smith S, Jones R, Hueber B, Kroll K, Varner V, Goepfert P, Jost S, Reeves RK. Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract. Aids (London, England). PMID 29734222 DOI: 10.1097/Qad.0000000000001855  0.402
2018 Patel S, Chorvinsky E, Albihani S, Cruz CR, Jones RB, Shpall EJ, Margolis DM, Ambinder RF, Bollard CM. HIV-Specific T Cells Generated from Naive T Cells Suppress HIV In Vitro and Recognize Wide Epitope Breadths. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 29724686 DOI: 10.1016/j.ymthe.2018.04.009  0.636
2018 Webb GM, Li S, Mwakalundwa G, Folkvord JM, Greene JM, Reed JS, Stanton JJ, Legasse AW, Hobbs T, Martin LD, Park BS, Whitney JB, Jeng EK, Wong HC, Nixon DF, ... Jones RB, et al. The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles. Blood Advances. 2: 76-84. PMID 29365313 DOI: 10.1182/Bloodadvances.2017012971  0.532
2018 Huang SH, Ren Y, Thomas AS, Chan D, Mueller S, Ward AR, Patel S, Bollard CM, Cruz CR, Karandish S, Truong R, Macedo AB, Bosque A, Kovacs C, Benko E, ... ... Jones RB, et al. Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells. The Journal of Clinical Investigation. PMID 29355843 DOI: 10.1172/Jci97555  0.838
2017 Thomas AS, Jones KL, Gandhi RT, McMahon DK, Cyktor JC, Chan D, Huang SH, Truong R, Bosque A, Macedo AB, Kovacs C, Benko E, Eron JJ, Bosch RJ, Lalama CM, ... ... Jones RB, et al. mT-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy. Plos Pathogens. 13: e1006629. PMID 28931091 DOI: 10.1371/Journal.Ppat.1006629  0.871
2017 Pollack RA, Jones RB, Pertea M, Bruner KM, Martin AR, Thomas AS, Capoferri AA, Beg SA, Huang SH, Karandish S, Hao H, Halper-Stromberg E, Yong PC, Kovacs C, Benko E, et al. Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. Cell Host & Microbe. 21: 494-506.e4. PMID 28407485 DOI: 10.1016/J.Chom.2017.03.008  0.862
2017 Mclean FE, Gathogo E, Goodall D, Jones R, Kinlcoh S, Post FA. Alemtuzumab induction therapy in HIV-positive renal transplant recipients. Aids (London, England). 31: 1047-1048. PMID 28350580 DOI: 10.1097/QAD.0000000000001413  0.332
2017 Raposo RA, de Mulder Rougvie M, Paquin-Proulx D, Brailey PM, Cabido VD, Zdinak PM, Thomas AS, Huang SH, Beckerle GA, Jones RB, Nixon DF. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. Jci Insight. 2: e85811. PMID 28097226 DOI: 10.1172/jci.insight.85811  0.855
2016 Jones RB, Mueller S, Kumari S, Vrbanac V, Genel S, Tager AM, Allen TM, Walker BD, Irvine DJ. Antigen recognition-triggered drug delivery mediated by nanocapsule-functionalized cytotoxic T-cells. Biomaterials. 117: 44-53. PMID 27936416 DOI: 10.1016/J.Biomaterials.2016.11.048  0.324
2016 Ranasinghe S, Lamothe PA, Soghoian DZ, Kazer SW, Cole MB, Shalek AK, Yosef N, Jones RB, Donaghey F, Nwonu C, Jani P, Clayton GM, Crawford F, White J, Montoya A, et al. Antiviral CD8(+) T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal Expansion. Immunity. 45: 917-930. PMID 27760342 DOI: 10.1016/J.Immuni.2016.09.015  0.47
2016 Willberg CB, Garrison KE, Jones RB, Meiklejohn DA, Spotts G, Liegler TJ, Ostrowski MA, Karlsson AC, Hecht FM, Nixon DF. Correction: Rapid Progressing Allele HLA-B35 Px Restricted Anti-HIV-1 CD8+ T Cells Recognize Vestigial CTL Epitopes. Plos One. 11: e0160293. PMID 27454121 DOI: 10.1371/journal.pone.0160293  0.708
2016 Patel S, Jones RB, Bollard CM, Nixon DF. T-cell therapies for HIV: Preclinical successes and current clinical strategies. Cytotherapy. PMID 27265874 DOI: 10.1016/j.jcyt.2016.04.007  0.671
2016 Milburn J, Jones R, Levy JB. Renal effects of novel antiretroviral drugs. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 27190354 DOI: 10.1093/ndt/gfw064  0.366
2016 Jones RB, Mueller S, O'Connor R, Rimpel K, Sloan DD, Karel D, Wong HC, Jeng EK, Thomas AS, Whitney JB, Lim SY, Kovacs C, Benko E, Karandish S, Huang SH, et al. A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes. Plos Pathogens. 12: e1005545. PMID 27082643 DOI: 10.1371/Journal.Ppat.1005545  0.866
2016 Rayment M, Bull L, Evans C, Rooney G, Delpech V, Jones R. A successful strategy to reduce loss to follow-up in HIV outpatient care: experiences of a large, urban clinic in the United Kingdom. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26890284 DOI: 10.1097/QAI.0000000000000962  0.368
2016 Booth JW, Hamzah L, Jose S, Horsfield C, O'Donnell P, McAdoo S, Kumar EA, Turner-Stokes T, Khatib N, Das P, Naftalin C, Mackie N, Kingdon E, Williams D, Hendry BM, ... ... Jones R, et al. Clinical characteristics and outcomes of HIV-associated immune complex kidney disease. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 26786550 DOI: 10.1093/ndt/gfv436  0.477
2016 Jones RB, Walker BD. HIV-specific CD8+ T cells and HIV eradication. The Journal of Clinical Investigation. 1-9. PMID 26731469 DOI: 10.1172/JCI80566  0.695
2015 Brockman MA, Jones RB, Brumme ZL. Challenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV Reservoirs. Frontiers in Immunology. 6: 506. PMID 26483795 DOI: 10.3389/Fimmu.2015.00506  0.6
2015 Anmole G, Kuang XT, Toyoda M, Martin E, Shahid A, Le AQ, Markle T, Baraki B, Jones RB, Ostrowski MA, Ueno T, Brumme ZL, Brockman MA. A robust and scalable TCR-based reporter cell assay to measure HIV-1 Nef-mediated T cell immune evasion. Journal of Immunological Methods. PMID 26319395 DOI: 10.1016/J.Jim.2015.08.010  0.683
2015 Jones R, Lacroix LJ, Nolte K. "Is Your Man Stepping Out?" An Online Pilot Study to Evaluate Acceptability of a Guide-Enhanced HIV Prevention Soap Opera Video Series and Feasibility of Recruitment by Facebook Advertising. The Journal of the Association of Nurses in Aids Care : Janac. 26: 368-86. PMID 26066692 DOI: 10.1016/j.jana.2015.01.004  0.456
2015 McFaul KM, Lim C, Jones R, Asboe D, Pozniak A, Sonecha S, Nwokolo N, Boffito M. Transmitted antiretroviral resistance in a large HIV directorate 2011-2014: a response. Aids (London, England). 29: 861-2. PMID 25985410 DOI: 10.1097/QAD.0000000000000601  0.48
2015 Yombi JC, Jones R, Pozniak A, Hougardy JM, Post FA. Monitoring of kidney function in HIV-positive patients. Hiv Medicine. PMID 25944246 DOI: 10.1111/hiv.12249  0.443
2015 Machtinger EL, Lavin SM, Hilliard S, Jones R, Haberer JE, Capito K, Dawson-Rose C. An expressive therapy group disclosure intervention for women living with HIV improves social support, self-efficacy, and the safety and quality of relationships: a qualitative analysis. The Journal of the Association of Nurses in Aids Care : Janac. 26: 187-98. PMID 25027284 DOI: 10.1016/J.Jana.2014.05.001  0.357
2014 McFaul K, Lim C, Jones R, Asboe D, Pozniak A, Sonecha S, Boffito M, Nwokolo N. Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013. Journal of the International Aids Society. 17: 19747. PMID 25397492  0.447
2014 Weidle PJ, Lecher S, Botts LW, Jones L, Spach DH, Alvarez J, Jones R, Thomas V. HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection. Journal of the American Pharmacists Association : Japha. 54: 486-92. PMID 25216878 DOI: 10.1331/JAPhA.2014.14045  0.517
2014 Jones RB, O'Connor R, Mueller S, Foley M, Szeto GL, Karel D, Lichterfeld M, Kovacs C, Ostrowski MA, Trocha A, Irvine DJ, Walker BD. Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes. Plos Pathogens. 10: e1004287. PMID 25122219 DOI: 10.1371/Journal.Ppat.1004287  0.795
2014 Gathogo E, Jose S, Jones R, Levy JB, Mackie NE, Booth J, Connolly J, Johnson M, Leen C, Williams D, Sabin CA, Post FA. End-stage kidney disease and kidney transplantation in HIV-positive patients: an observational cohort study. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 177-80. PMID 25072607 DOI: 10.1097/QAI.0000000000000291  0.362
2014 Sheppard NC, Jones RB, Burwitz BJ, Nimityongskul FA, Newman LP, Buechler MB, Reed JS, Piaskowski SM, Weisgrau KL, Castrovinci PA, Wilson NA, Ostrowski MA, Park B, Nixon DF, Rakasz EG, et al. Vaccination against endogenous retrotransposable element consensus sequences does not protect rhesus macaques from SIVsmE660 infection and replication. Plos One. 9: e92012. PMID 24651676 DOI: 10.1371/journal.pone.0092012  0.718
2014 Gathogo EN, Hamzah L, Hilton R, Marshall N, Ashley C, Harber M, Levy JB, Jones R, Boffito M, Khoo SH, Drage M, Bhagani S, Post FA. Kidney transplantation in HIV-positive adults: the UK experience. International Journal of Std & Aids. 25: 57-66. PMID 23970634 DOI: 10.1177/0956462413493266  0.42
2013 Jones RB, Song H, Xu Y, Garrison KE, Buzdin AA, Anwar N, Hunter DV, Mujib S, Mihajlovic V, Martin E, Lee E, Kuciak M, Raposo RA, Bozorgzad A, Meiklejohn DA, et al. LINE-1 retrotransposable element DNA accumulates in HIV-1-infected cells. Journal of Virology. 87: 13307-20. PMID 24089548 DOI: 10.1128/Jvi.02257-13  0.736
2013 Rayment M, Doku E, Thornton A, Pearn M, Sudhanva M, Jones R, Nardone A, Roberts P, Tenant-Flowers M, Anderson J, Sullivan AK, Atkins M. Automatic oral fluid-based HIV testing in HIV screening programmes: automatic for the people. Hiv Medicine. 14: 49-52. PMID 24033905 DOI: 10.1111/hiv.12063  0.458
2013 Jones R, Hoover DR, Lacroix LJ. A randomized controlled trial of soap opera videos streamed to smartphones to reduce risk of sexually transmitted human immunodeficiency virus (HIV) in young urban African American women. Nursing Outlook. 61: 205-215.e3. PMID 23743482 DOI: 10.1016/j.outlook.2013.03.006  0.353
2013 Jones RB, Leal FE, Hasenkrug AM, Segurado AC, Nixon DF, Ostrowski MA, Kallas EG. Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods. Journal of Negative Results in Biomedicine. 12: 3. PMID 23305161 DOI: 10.1186/1477-5751-12-3  0.583
2013 Ndhlovu ZM, Chibnik LB, Proudfoot J, Vine S, McMullen A, Cesa K, Porichis F, Jones RB, Alvino DM, Hart MG, Stampouloglou E, Piechocka-Trocha A, Kadie C, Pereyra F, Heckerman D, et al. High-dimensional immunomonitoring models of HIV-1-specific CD8 T-cell responses accurately identify subjects achieving spontaneous viral control. Blood. 121: 801-11. PMID 23233659 DOI: 10.1182/Blood-2012-06-436295  0.565
2013 Hughes A, Hope RL, Nwokolo N, Ward B, Jones R, Von Schweitzer M, Boag F. Meeting complex needs: young people with HIV in London. Hiv Medicine. 14: 145-52. PMID 22998645 DOI: 10.1111/j.1468-1293.2012.01049.x  0.409
2012 McClure M, Singh GJ, Rayment M, Jones R, Levy JB. Clinical outcomes of a combined HIV and renal clinic. Clinical Kidney Journal. 5: 530-4. PMID 26069796 DOI: 10.1093/ckj/sfs141  0.391
2012 Duncan S, Jones R, McIntyre M, Pilsniak A, Trott J, Desmond N. Managing HIV in pregnancy in a community-based sexual health clinic: a decade in review. International Journal of Std & Aids. 23: 806-9. PMID 23155101 DOI: 10.1258/ijsa.2012.011466  0.424
2012 Jones RB, Garrison KE, Mujib S, Mihajlovic V, Aidarus N, Hunter DV, Martin E, John VM, Zhan W, Faruk NF, Gyenes G, Sheppard NC, Priumboom-Brees IM, Goodwin DA, Chen L, et al. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates. The Journal of Clinical Investigation. 122: 4473-89. PMID 23143309 DOI: 10.1172/Jci64560  0.805
2012 Gedela K, Nelson M, Francis N, Mohabeer M, Jones R. Cutaneous aspergillosis associated with HIV infection. International Journal of Std & Aids. 23: 679-80. PMID 23033527 DOI: 10.1258/ijsa.2012.011437  0.541
2012 Ormsby CE, Sengupta D, Tandon R, Deeks SG, Martin JN, Jones RB, Ostrowski MA, Garrison KE, Vázquez-Pérez JA, Reyes-Terán G, Nixon DF. Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection. Plos One. 7: e41021. PMID 22879884 DOI: 10.1371/Journal.Pone.0041021  0.759
2012 Sakhdari A, Mujib S, Vali B, Yue FY, MacParland S, Clayton K, Jones RB, Liu J, Lee EY, Benko E, Kovacs C, Gommerman J, Kaul R, Ostrowski MA. Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infection. Plos One. 7: e40146. PMID 22792231 DOI: 10.1371/Journal.Pone.0040146  0.782
2012 Thornton AC, Rayment M, Elam G, Atkins M, Jones R, Nardone A, Roberts P, Tenant-Flowers M, Anderson J, Sullivan AK. Exploring staff attitudes to routine HIV testing in non-traditional settings: a qualitative study in four healthcare facilities. Sexually Transmitted Infections. 88: 601-6. PMID 22773329 DOI: 10.1136/sextrans-2012-050584  0.48
2012 Rayment M, Thornton A, Mandalia S, Elam G, Atkins M, Jones R, Nardone A, Roberts P, Tenant-Flowers M, Anderson J, Sullivan AK. HIV testing in non-traditional settings--the HINTS study: a multi-centre observational study of feasibility and acceptability. Plos One. 7: e39530. PMID 22745777 DOI: 10.1371/journal.pone.0039530  0.489
2012 Sacha JB, Kim IJ, Chen L, Ullah JH, Goodwin DA, Simmons HA, Schenkman DI, von Pelchrzim F, Gifford RJ, Nimityongskul FA, Newman LP, Wildeboer S, Lappin PB, Hammond D, Castrovinci P, ... ... Jones RB, et al. Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenic. Journal of Immunology (Baltimore, Md. : 1950). 189: 1467-79. PMID 22745376 DOI: 10.4049/Jimmunol.1200079  0.662
2012 Jones RB, Kovacs C, Chun TW, Ostrowski MA. Short communication: HIV type 1 accumulates in influenza-specific T cells in subjects receiving seasonal vaccination in the context of effective antiretroviral therapy. Aids Research and Human Retroviruses. 28: 1687-92. PMID 22734882 DOI: 10.1089/AID.2012.0115  0.786
2012 Duncan S, Koh AL, Jones R, Desmond N. Testing the children of HIV-positive mothers. International Journal of Std & Aids. 23: 224-5. PMID 22581884 DOI: 10.1258/ijsa.2011.011303  0.382
2012 Jones R, Lacroix LJ. Streaming weekly soap opera video episodes to smartphones in a randomized controlled trial to reduce HIV risk in young urban African American/black women. Aids and Behavior. 16: 1341-58. PMID 22430640 DOI: 10.1007/s10461-012-0170-9  0.322
2012 Mujib S, Jones RB, Lo C, Aidarus N, Clayton K, Sakhdari A, Benko E, Kovacs C, Ostrowski MA. Antigen-independent induction of Tim-3 expression on human T cells by the common γ-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway. Journal of Immunology (Baltimore, Md. : 1950). 188: 3745-56. PMID 22422881 DOI: 10.4049/jimmunol.1102609  0.66
2012 Ndhlovu LC, Lopez-Vergès S, Barbour JD, Jones RB, Jha AR, Long BR, Schoeffler EC, Fujita T, Nixon DF, Lanier LL. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood. 119: 3734-43. PMID 22383801 DOI: 10.1182/Blood-2011-11-392951  0.316
2012 Sheth PM, Yi TJ, Kovacs C, Kemal KS, Jones RB, Osborne B, Pilon R, la Porte C, Ostrowski M, Mazzulli T, Burger H, Weiser B, Kaul R. Mucosal correlates of isolated HIV semen shedding during effective antiretroviral therapy. Mucosal Immunology. 5: 248-57. PMID 22318494 DOI: 10.1038/Mi.2012.1  0.785
2012 Jones RB, John VM, Hunter DV, Martin E, Mujib S, Mihajlovic V, Burgers PC, Luider TM, Gyenes G, Sheppard NC, Sengupta D, Tandon R, Yue FY, Benko E, Kovacs C, et al. Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening. Clinical and Vaccine Immunology : Cvi. 19: 288-92. PMID 22205657 DOI: 10.1128/CVI.05583-11  0.64
2012 Wang C, McPherson AJ, Jones RB, Kawamura KS, Lin GH, Lang PA, Ambagala T, Pellegrini M, Calzascia T, Aidarus N, Elford AR, Yue FY, Kremmer E, Kovacs CM, Benko E, et al. Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection. The Journal of Experimental Medicine. 209: 77-91. PMID 22184633 DOI: 10.1084/Jem.20110675  0.766
2011 Tandon R, SenGupta D, Ndhlovu LC, Vieira RG, Jones RB, York VA, Vieira VA, Sharp ER, Wiznia AA, Ostrowski MA, Rosenberg MG, Nixon DF. Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects. Journal of Virology. 85: 11526-31. PMID 21880743 DOI: 10.1128/Jvi.05418-11  0.812
2011 Nelson M, Dockrell D, Edwards S, Angus B, Barton S, Beeching N, Bergin C, Boffito M, Breen R, Cartledge J, Clarke S, Fisher M, Freedman A, Gazzard B, ... ... Jones R, et al. British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. Hiv Medicine. 12: 1-140. PMID 21851517 DOI: 10.1111/J.1468-1293.2011.00944_1.X  0.539
2011 Jones R. Handheld computers to run ACASI to assess HIV risk and deliver tailored soap opera video feedback: acceptability among young adult urban women. The Journal of the Association of Nurses in Aids Care : Janac. 23: 260-7. PMID 21664834 DOI: 10.1016/j.jana.2011.04.001  0.312
2011 Ndhlovu LC, Leal FE, Hasenkrug AM, Jha AR, Carvalho KI, Eccles-James IG, Bruno FR, Vieira RG, York VA, Chew GM, Jones RB, Tanaka Y, Neto WK, Sanabani SS, Ostrowski MA, et al. HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications. Plos Neglected Tropical Diseases. 5: e1030. PMID 21541358 DOI: 10.1371/journal.pntd.0001030  0.679
2011 SenGupta D, Tandon R, Vieira RG, Ndhlovu LC, Lown-Hecht R, Ormsby CE, Loh L, Jones RB, Garrison KE, Martin JN, York VA, Spotts G, Reyes-Terán G, Ostrowski MA, Hecht FM, et al. Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection. Journal of Virology. 85: 6977-85. PMID 21525339 DOI: 10.1128/Jvi.00179-11  0.826
2011 Czoski-Murray C, Karnon J, Jones R, Smith K, Kinghorn G. Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer. Health Technology Assessment (Winchester, England). 14: iii-iv, ix-x, 1-101. PMID 21083999 DOI: 10.3310/hta14530  0.349
2010 Vali B, Jones RB, Sakhdari A, Sheth PM, Clayton K, Yue FY, Gyenes G, Wong D, Klein MB, Saeed S, Benko E, Kovacs C, Kaul R, Ostrowski MA. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression. European Journal of Immunology. 40: 2493-505. PMID 20623550 DOI: 10.1002/Eji.201040340  0.68
2010 Harrison AL, Olsson ML, Jones RB, Ramkumar S, Sakac D, Binnington B, Henry S, Lingwood CA, Branch DR. A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms. Glycoconjugate Journal. 27: 515-24. PMID 20582467 DOI: 10.1007/s10719-010-9297-y  0.578
2010 Yue FY, Lo C, Sakhdari A, Lee EY, Kovacs CM, Benko E, Liu J, Song H, Jones RB, Sheth P, Chege D, Kaul R, Ostrowski MA. HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control. Journal of Immunology (Baltimore, Md. : 1950). 185: 498-506. PMID 20519650 DOI: 10.4049/Jimmunol.0903915  0.764
2010 Lee EY, Yue FY, Jones RB, Lo C, Sheth P, Hyrcza MD, Kovacs C, Benko E, Kaul R, Ostrowski M. The impact of CCL3L1 copy number in an HIV-1-infected white population. Aids (London, England). 24: 1589-91. PMID 20442635 DOI: 10.1097/Qad.0B013E3283398294  0.841
2010 Willberg CB, Garrison KE, Jones RB, Meiklejohn DJ, Spotts G, Liegler TJ, Ostrowski MA, Karlsson AC, Hecht FM, Nixon DF. Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes. Plos One. 5: e10249. PMID 20422053 DOI: 10.1371/Journal.Pone.0010249  0.726
2010 Jones R, Brown D, Nelson M, Low E, Bhagani S, Atkins M, Danta M, Dusheiko G, Pybus O, Asboe D. Re-emergent Hepatitis C Viremia After Apparent Clearance in HIV-Positive Men Who Have Sex With Men: Reinfection or Late Recurrence? Journal of Acquired Immune Deficiency Syndromes. 53: 547-550. PMID 20220378 DOI: 10.1097/Qai.0B013E3181Ba41E2  0.346
2010 Yue FY, Lo C, Sakhdari A, Lee EY, Kovacs CM, Benko E, Liu J, Song H, Jones RB, Sheth P, Chege D, Kaul R, Ostrowski MA. HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control (Journal of Immunology (2010) 185, (498-506)) Journal of Immunology. 185: 2632-2633. DOI: 10.4049/jimmunol.1090073  0.785
2009 Sheth PM, Kovacs C, Kemal KS, Jones RB, Raboud JM, Pilon R, la Porte C, Ostrowski M, Loutfy M, Burger H, Weiser B, Kaul R. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy. Aids (London, England). 23: 2050-4. PMID 19710596 DOI: 10.1097/Qad.0B013E3283303E04  0.723
2009 Jones RB, Yue FY, Gu XX, Hunter DV, Mujib S, Gyenes G, Mason RD, Mohamed R, MacDonald KS, Kovacs C, Ostrowski MA. Human immunodeficiency virus type 1 escapes from interleukin-2-producing CD4+ T-cell responses without high-frequency fixation of mutations. Journal of Virology. 83: 8722-32. PMID 19553327 DOI: 10.1128/JVI.00433-09  0.783
2009 Stebbing J, Scourfield A, Koh G, Taylor C, Taylor S, Wilkins E, Gazzard B, Nelson M, Jones R. A multicentre cohort experience with double-boosted protease inhibitors Journal of Antimicrobial Chemotherapy. 64: 434-435. PMID 19474068 DOI: 10.1093/Jac/Dkp192  0.334
2009 Jones R, Pozniak A. So you want to be ... a specialist in HIV/AIDS medicine. British Journal of Hospital Medicine (London, England : 2005). 70: M64. PMID 19357591 DOI: 10.12968/hmed.2009.70.Sup4.41643  0.526
2008 Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha AR, Long BR, Wong JC, Satkunarajah M, Schweneker M, Chapman JM, Gyenes G, Vali B, Hyrcza MD, Yue FY, Kovacs C, et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. The Journal of Experimental Medicine. 205: 2763-79. PMID 19001139 DOI: 10.1084/Jem.20081398  0.879
2008 Vali B, Yue FY, Jones RB, Sheth PM, Kaul R, Betts MR, Wong D, Kovacs C, Loutfy M, Common A, Halpenny R, Ostrowski MA. HIV-specific T-cells accumulate in the liver in HCV/HIV co-infection. Plos One. 3: e3454. PMID 18941622 DOI: 10.1371/Journal.Pone.0003454  0.728
2008 Sadek M, Yue FY, Lee EY, Gyenes G, Jones RB, Hoffstein V, Munoz DG, Fong I, Ostrowski M. Clinical and immunologic features of an atypical intracranial mycobacterium avium complex (MAC) infection compared with those of pulmonary MAC infections. Clinical and Vaccine Immunology : Cvi. 15: 1580-9. PMID 18701648 DOI: 10.1128/Cvi.00173-08  0.574
2008 Liu J, Yu Q, Stone GW, Yue FY, Ngai N, Jones RB, Kornbluth RS, Ostrowski MA. CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals. Vaccine. 26: 4062-72. PMID 18562053 DOI: 10.1016/J.Vaccine.2008.05.018  0.776
2008 Jones R. Soap opera video on handheld computers to reduce young urban women's HIV sex risk. Aids and Behavior. 12: 876-84. PMID 18535900 DOI: 10.1007/s10461-008-9416-y  0.318
2008 Post FA, Campbell LJ, Hamzah L, Collins L, Jones R, Siwani R, Johnson L, Fisher M, Holt SG, Bhagani S, Frankel AH, Wilkins E, Ainsworth JG, Larbalestier N, Macallan DC, et al. Predictors of renal outcome in HIV-associated nephropathy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: 1282-9. PMID 18444868 DOI: 10.1086/529385  0.333
2008 Jones RB, Garrison KE, Wong JC, Duan EH, Nixon DF, Ostrowski MA. Nucleoside analogue reverse transcriptase inhibitors differentially inhibit human LINE-1 retrotransposition. Plos One. 3: e1547. PMID 18253495 DOI: 10.1371/Journal.Pone.0001547  0.474
2007 Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, Chapman JM, Erickson AL, Agrawal A, Spotts G, Hecht FM, Rakoff-Nahoum S, Lenz J, Ostrowski MA, Nixon DF. T cell responses to human endogenous retroviruses in HIV-1 infection. Plos Pathogens. 3: e165. PMID 17997601 DOI: 10.1371/Journal.Ppat.0030165  0.818
2007 Jones R, Nelson M. The role of receptors in the HIV-1 entry process. European Journal of Medical Research. 12: 391-6. PMID 17933719  0.499
2007 Jones R, Scott C, Nelson M, Levy J. Renal complications in HIV. International Journal of Clinical Practice. 61: 991-8. PMID 17504361 DOI: 10.1111/j.1742-1241.2007.01376.x  0.379
2007 Richter DL, Dauner KN, Lindley LL, Reininger BM, Oglesby WH, Prince MS, Thompson-Robinson M, Jones R, Potts LH. Evaluation results of the CDC/ASPH Institute for HIV Prevention Leadership: a capacity-building educational program for HIV prevention program managers. Journal of Public Health Management and Practice : Jphmp. S64-71. PMID 17159470 DOI: 10.1097/00124784-200701001-00011  0.418
2007 Jones R, Pozniak A. So you want to be... a specialist in HIV/AIDS medicine. British Journal of Hospital Medicine (London, England : 2005). 67: M199. PMID 17069129 DOI: 10.12968/hmed.2006.67.Sup10.22076  0.526
2006 Richter DL, Potts LH, Prince MS, Dauner KN, Reininger BM, Thompson-Robinson M, Corwin SJ, Getty C, Jones R. Development of a curriculum to enhance community-based organizations' capacity for effective HIV prevention programming and management. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 18: 362-74. PMID 16961452 DOI: 10.1521/Aeap.2006.18.4.362  0.374
2006 Jones R, Gazzard B. HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitors. Expert Review of Anti-Infective Therapy. 4: 303-12. PMID 16597210 DOI: 10.1586/14787210.4.2.303  0.439
2006 Campos-Outcalt D, Mickey T, Weisbuch J, Jones R. Integrating routine HIV testing into a public health STD clinic. Public Health Reports (Washington, D.C. : 1974). 121: 175-80. PMID 16528951 DOI: 10.1177/003335490612100212  0.337
2006 Jones R, Dunning J, Nelson M. HIV and hepatitis C co-infection. International Journal of Clinical Practice. 59: 1082-7. PMID 16115185 DOI: 10.1111/j.1742-1241.2005.00596.x  0.369
2005 Jones R, Gazzard B, Halima Y. Preventing HIV infection. Bmj (Clinical Research Ed.). 331: 1285-6. PMID 16321996 DOI: 10.1136/bmj.331.7528.1285  0.553
2005 Jones R, Sawleshwarkar S, Michailidis C, Jackson A, Mandalia S, Stebbing J, Bower M, Nelson M, Gazzard BG, Moyle GJ. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone. Hiv Medicine. 6: 396-402. PMID 16268821 DOI: 10.1111/j.1468-1293.2005.00325.x  0.36
2005 Stebbing J, Sawleshwarkar S, Michailidis C, Jones R, Bower M, Mandalia S, Nelson M, Gazzard B. Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people. Postgraduate Medical Journal. 81: 586-8. PMID 16143689 DOI: 10.1136/pgmj.2004.030841  0.499
2005 Waters L, Stebbing J, Jones R, Mandalia S, Bower M, Stefanovic M, Nelson M, Gazzard B. The effect of statins on HIV rebound and blips. Journal of Acquired Immune Deficiency Syndromes (1999). 39: 637-8. PMID 16044021  0.534
2002 Keane FE, Neale J, Phillips T, Heard L, Jones R, Guttridge B, Bendall R. Offering routine antenatal testing for HIV and hepatitis B in the rural setting of Cornwall. Sexually Transmitted Infections. 78: 133-4. PMID 12081176 DOI: 10.1136/sti.78.2.133  0.454
2000 Whittet S, Trail P, de Ruiter A, O'Sullivan D, Jones R. General practitioners' attitudes and beliefs on antenatal testing for HIV: postal questionnaire survey. Bmj (Clinical Research Ed.). 321: 934. PMID 11030683 DOI: 10.1136/bmj.321.7266.934  0.455
1999 Ades AE, Walker J, Botting B, Parker S, Cubitt D, Jones R. Effect of the worldwide epidemic on HIV prevalence in the United Kingdom: record linkage in anonymous neonatal seroprevalence surveys. Aids. 13: 2437-2443. PMID 10597786 DOI: 10.1097/00002030-199912030-00016  0.467
Show low-probability matches.